Dozens of attorneys general urge FDA to crack down on counterfeit obesity drugs ‘Supply shortages and high costs have created opportunities for wrongdoers to cash in and endanger consumers,’ they wrote FDA

https://www.statnews.com/pharmalot/2025/02/20/fda-counterfeit-hims-wegovy-zepbound-obesity-semaglutide-novo-lilly-compounding-pharmacy-obesity-weight-diabetes/